Krystal Biotech Inc (KRYS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 89,159 | 10,932 | -139,975 | -69,570 | -32,167 |
| Depreciation Amortization | 6,714 | 5,911 | 3,385 | 2,769 | 1,851 |
| Accounts receivable | -62,706 | -42,040 | 0 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,011 | -101 | -1,254 | 712 | 783 |
| Other Working Capital | -14,457 | -38,522 | 2,657 | 2,506 | 917 |
| Other Operating Activity | 103,699 | -24,984 | 34,618 | 15,645 | 2,533 |
| Operating Cash Flow | $123,420 | $-88,804 | $-100,569 | $-47,938 | $-26,083 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -159,201 | -5,563 | -61,104 | 32,028 | 6,867 |
| PPE Investments | -4,238 | 88,201 | -52,979 | -68,336 | -14,843 |
| Purchase Of Investment | N/A | N/A | N/A | -190,462 | -3,205 |
| Investing Cash Flow | $-163,439 | $82,638 | $-114,083 | $-226,770 | $-11,181 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 32,400 | 203,499 | 35,996 | 355,645 | 118,019 |
| Other Financing Activity | -5,386 | -749 | -649 | -7,960 | 0 |
| Financing Cash Flow | $27,014 | $202,750 | $35,347 | $347,685 | $118,019 |
| Exchange Rate Effect | -458 | -156 | -41 | N/A | N/A |
| Beginning Cash Position | 358,328 | 161,900 | 341,246 | 268,269 | 187,514 |
| End Cash Position | 344,865 | 358,328 | 161,900 | 341,246 | 268,269 |
| Net Cash Flow | $-13,463 | $196,428 | $-179,346 | $72,977 | $80,755 |
| Free Cash Flow | |||||
| Operating Cash Flow | 123,420 | -88,804 | -100,569 | -47,938 | -26,083 |
| Capital Expenditure | -4,238 | -11,799 | -52,979 | -68,336 | -14,843 |
| Free Cash Flow | 119,182 | -100,603 | -153,548 | -116,274 | -40,926 |